ImportRefusal LogoImportRefusal

Zhejiang Ruibang Laboratories Co., Ltd

⚠️ Moderate Risk

FEI: 3001027745 • Wenzhou, Zhejiang • CHINA

FEI

FEI Number

3001027745

📍

Location

Wenzhou, Zhejiang

🇨🇳

Country

CHINA
🏢

Address

Economic, 578 Binhai Ten Road; Longwan, Wenzhou, Zhejiang, China

Moderate Risk

FDA Import Risk Assessment

32.1
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

4
Total Refusals
6
Unique Violations
6/11/2013
Latest Refusal
7/3/2002
Earliest Refusal

Score Breakdown

Violation Severity
60.0×40%
Refusal Volume
25.9×30%
Recency
0.0×20%
Frequency
3.6×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1183×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

753×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

161×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

28801×

RXCOMPOUND

the labeling fails to bear, at a minimum, the symbol "Rx only."

3331×

LACKS FIRM

The article is in package form and appears to not bear a label containing the name and place of business of the manufacturer, packer, or distributor.

4831×

DRUG NAME

The article appears to be a drug and fails to bear the proprietary or established name and/or name and quantity of each active ingredient.

Refusal History

DateProductViolationsDivision
6/11/2013
62GDY89CYCLOSPORINE (ANTI-INFLAMMATORY)
75UNAPPROVED
Los Angeles District Office (LOS-DO)
10/18/2012
62GCZ89CYCLOSPORINE (ANTI-INFLAMMATORY)
118NOT LISTED
75UNAPPROVED
San Francisco District Office (SAN-DO)
12/11/2006
56KIR99MISCELLANEOUS ANTIBIOTICS, N.E.C.
118NOT LISTED
16DIRECTIONS
2880RXCOMPOUND
333LACKS FIRM
483DRUG NAME
Detroit District Office (DET-DO)
7/3/2002
62GBZ89CYCLOSPORINE (ANTI-INFLAMMATORY)
118NOT LISTED
75UNAPPROVED
Cincinnati District Office (CIN-DO)

Frequently Asked Questions

What is Zhejiang Ruibang Laboratories Co., Ltd's FDA import refusal history?

Zhejiang Ruibang Laboratories Co., Ltd (FEI: 3001027745) has 4 FDA import refusal record(s) in our database, spanning from 7/3/2002 to 6/11/2013.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Zhejiang Ruibang Laboratories Co., Ltd's FEI number is 3001027745.

What types of violations has Zhejiang Ruibang Laboratories Co., Ltd received?

Zhejiang Ruibang Laboratories Co., Ltd has been cited for 6 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Zhejiang Ruibang Laboratories Co., Ltd come from?

All FDA import refusal data for Zhejiang Ruibang Laboratories Co., Ltd is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.